Pharming Group (PHAR) News Today $10.10 -0.25 (-2.42%) Closing price 07/15/2025 03:26 PM EasternExtended Trading$10.12 +0.02 (+0.21%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PHAR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Pharming Group N.V. (PHGUF) stock price, news, quote & history ...July 11, 2025 | sg.finance.yahoo.comPharming Group (NASDAQ:PHAR) Trading Down 3.5% - Should You Sell?July 9, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - What's Next?July 8, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Down - What's Next?July 3, 2025 | marketbeat.comAS:PHAR Financials | Pharming Group NV - Investing.comJuly 2, 2025 | investing.comPharming Group (NASDAQ:PHAR) Stock Price Down 4.9% - Here's What HappenedJuly 1, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - Here's WhyJune 30, 2025 | marketbeat.comPharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS ...June 25, 2025 | morningstar.comMPharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve ... - NasdaqJune 25, 2025 | nasdaq.comPharming Group (NASDAQ:PHAR) Shares Down 3.2% - Here's WhyJune 18, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Here's What HappenedJune 17, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - Time to Buy?June 16, 2025 | marketbeat.comShort Interest in Pharming Group (NASDAQ:PHAR) Expands By 169.2%June 13, 2025 | marketbeat.comEuropean Penny Stocks Under €200M Market Cap To WatchJune 13, 2025 | uk.finance.yahoo.comPharming Group (NASDAQ:PHAR) Trading 3.9% Higher - Here's What HappenedJune 12, 2025 | marketbeat.comPharming Group reports on results of the 2025 Annual General Meeting of ShareholdersJune 11, 2025 | finance.yahoo.comPharming Group Announces Key Board Appointments and Approvals at 2025 AGMJune 11, 2025 | tipranks.comPharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Here's WhyJune 11, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Down 4.6% - Here's What HappenedJune 10, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Stock Price Up 6.7% - Here's What HappenedJune 6, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Down - Should You Sell?June 5, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - Here's What HappenedJune 4, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Reaches New 1-Year High - What's Next?June 3, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Large Decline in Short InterestJune 3, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Stock Price Up 10.1% - Here's What HappenedMay 31, 2025 | marketbeat.comPharming Group to participate in June investor conferencesMay 28, 2025 | finance.yahoo.comPharming Group to participate in June investor conferences | PHARM Stock NewsMay 28, 2025 | gurufocus.comQ2 EPS Estimates for Pharming Group Decreased by AnalystMay 13, 2025 | marketbeat.comPharming Group First Quarter 2025 Earnings: US$0.022 loss per share (vs US$0.019 loss in 1Q 2024)May 10, 2025 | finance.yahoo.comPharming Group N.V. (PHAR) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comPharming Group N.V. 2025 Q1 - Results - Earnings Call PresentationMay 9, 2025 | seekingalpha.comPharming Group N.V.: Pharming Group reports first quarter 2025 financial results and provides business updateMay 8, 2025 | finanznachrichten.dePharming Group reports first quarter 2025 financial results and provides business update | ...May 8, 2025 | gurufocus.comEarnings To Watch: Pharming Group (PHGUF) Reports Q1 2025 ResultMay 7, 2025 | gurufocus.comPharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive DirectorApril 30, 2025 | finance.yahoo.comPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - What's Next?April 30, 2025 | marketbeat.comPharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of ...April 30, 2025 | gurufocus.comShort Interest in Pharming Group (NASDAQ:PHAR) Declines By 36.0%April 30, 2025 | marketbeat.comPharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical ...April 25, 2025 | gurufocus.comPharming Group to Present Key Findings at Clinical Immunology Society MeetingApril 25, 2025 | tipranks.comPharming receives positive recommendation from NICE for Joenja®?(leniolisib) as a treatment for APDSApril 24, 2025 | tmcnet.comPharming Group to report first quarter 2025 financial results on May 8 | PHARM Stock NewsApril 24, 2025 | gurufocus.comPharming Group to report first quarter 2025 financial results on May 8 | PHARM Stock NewsApril 24, 2025 | gurufocus.comPharming Group (PHAR) Receives NICE Approval for Joenja in England and Wales | PHAR Stock NewsApril 23, 2025 | gurufocus.comPharming Group’s Joenja® Receives NICE Recommendation for APDS TreatmentApril 23, 2025 | tipranks.comPharming Group’s Strategic Expansion and NICE Endorsement Drive Buy RatingApril 23, 2025 | tipranks.comPharming Group (NASDAQ:PHAR) Shares Up 4.3% - Should You Buy?April 18, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Short Interest Down 56.9% in MarchApril 18, 2025 | marketbeat.comEuropean Opportunities: 3 Penny Stocks With Market Caps Larger Than €10MApril 15, 2025 | finance.yahoo.comPharming Group (NASDAQ:PHAR) Trading 10.3% Higher - Here's What HappenedApril 9, 2025 | marketbeat.com Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Email Address PHAR Media Mentions By Week PHAR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHAR News Sentiment▼0.760.97▲Average Medical News Sentiment PHAR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHAR Articles This Week▼33▲PHAR Articles Average Week Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RARE News Today ALVO News Today AMRX News Today MIRM News Today CPRX News Today ARWR News Today IBRX News Today OGN News Today APLS News Today XENE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHAR) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group N.V. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PHAR Stock Alerts